Bruce L. A. Carter, Director at ENANTA PHARMACEUTICALS INC (ENTA), sold 10,468 shares at $90.02 ($942K) on 2019-02-11, disclosed to the SEC on 2019-02-13.
Open-market sale of $942k ENTA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.02 | 2,734 | $246K | 26.1% |
| 2 | $90.02 | 2,734 | $246K | 26.1% |
| 3 | $90.00 | 5,000 | $450K | 47.8% |
| Total | $90.01 avg | 10,468 | $942K | 100% |
| Filing → |
| MRTX | SELL | 2021-04-06 | $746K | — | Filing → |
| MRTX | SELL | 2021-02-03 | $430K | — | Filing → |
| MRTX | SELL | 2020-12-16 | $1.1M | — | Filing → |